Patient Guide: A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 146 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05646862
Status: ACTIVE_NOT_RECRUITING
Condition: Breast Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 146 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Los Alamitos, California
  • Los Angeles, California
  • Sacramento, California
  • • And 143 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily